Prednisolone may harm patients with inflammatory diseases

05/19/2013 | PhysiciansBriefing.com

Administering low-dose prednisolone to patients with inflammatory rheumatologic disease without diabetes mellitus can interrupt carbohydrate metabolism, according to a small study in Diabetes Care. "Our findings demonstrate that low-dose prednisolone exerts a major deleterious effect on carbohydrate metabolism. When prescribing glucocorticoids, careful consideration should be given to these potential adverse metabolic effects, and alternative anti-inflammatory agents should be considered," researchers said.

View Full Article in:

PhysiciansBriefing.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Abbott
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA